OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients

Autoimmunity Reviews

Volumn 7, Issue 1, 2007, Pages 52-58

  Bassi, N ^a   Ghirardello, A ^a   Iaccarino, L ^a   Zampieri, S ^a   Rampudda, M E ^a   Atzeni, F ^b   Sarzi Puttini, P ^b   Shoenfeld, Y ^c   Doria, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

2GPI; Atherosclerosis; HSP60 65; OxLDL; OxLDL 2GPI

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 65 ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY;

ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TOLERANCE; HUMAN; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTIGEN ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIGEN-ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTOANTIBODIES; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, NATURAL; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 35448983542     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.06.003     Document Type: Review

References (40)

1. Sherer Y., Gorstein A., Fritzler M.J., and Shoenfeld Y. Autoantibodies explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34 (2004) 501-537
2. Shoenfeld Y., Gerli R., Doria A., Matsuura E., Cerinic M.M., Ronda N., et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112 (2005) 3337-3347
3. Doria A., Sarzi-Puttini P., and Shoenfeld Y. 2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20. Autoimmun Rev vol. 5 (2006) 55-63
4. Sarzi-Puttini P., Atzeni F., Doria A., Iaccarino L., and Turiel M. Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. Lupus 14 (2005) 780-784
5. Doria A., Iaccarino L., Sarzi-Puttini P., Atzeni F., Turiel M., and Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 14 (2005) 683-686
6. Zampieri S., Iaccarino L., Ghirardello A., Taricone E., Arienti S., Sarzi-Puttini P., et al. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann NY Acad Sci 1051 (2005) 351-361
7. Turiel M., Peretti R., Sarzi-Puttini P., Atzeni F., and Doria A. Cardiac imaging techniques in systemic autoimmune diseases. Lupus 14 (2005) 727-731
8. Doria A., Shoenfeld Y., Wu R., Gambari P.F., Puato M., Ghirardello A., et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62 (2003) 1071-1077
9. Gordon P.A., George J., Khamashta M., Harats D., Hughes G., and Shoenfeld Y. Atherosclerosis and autoimmunity. Lupus 10 (2001) 249-252
10. Doria A., Sherer Y., Meroni P.L., and Shoenfeld Y. Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am 31 (2005) 355-362
11. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107 (2001) 1255-1262
12. 1 integrin. J Clin Invest 103 (1999) 613-625
13. 2-glycoprotein I. Cardiovasc Res 62 (2004) 603-609
14. Toubi E., and Shoenfeld Y. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?. Lupus 14 (2005) 665-669
15. Harats D., Yacov N., Gilburd B., Shoenfeld Y., and George J. Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J Am Coll Cardiol 40 (2002) 1333-1338
16. Lopez L.R., Salazar-Paramo M.M., Palafox-Sanchez C., Hurley B.L., Matsuura E., and Garcia-De La Torre I. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implication in autoimmune-mediated atherosclerosis. Lupus 15 (2006) 80-86
17. Davi G., and Falco A. Oxidant stress, inflammation and atherogenesis. Lupus 14 (2005) 760-764
18. George J., Afek A., Gilburd B., Harats D., and Shoenfeld Y. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9 (2000) 223-227
19. Sherer Y., Tenenbaum A., Blank M., Shemesh J., Harats D., Fisman E.Z., et al. Autoantibodies to oxidized low-density lipoprotein in coronary artery disease. Am J Hypertens 14 (2001) 149-154
20. Radulescu L., Stancu C., and Antohe F. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Med Sci Monit 10 (2004) 207-214
21. Matsuura E., Kobayashi K., Tabuchi M., and Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45 (2006) 466-486
22. Su J., Georgiades A., Wu R., Thulin T., de Faire U., and Frostegård J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 188 (2006) 160-166
23. Shaw P.X., Hörkkö S., Tsimikas S., Chang M.K., Palinski W., Silverman G.J., et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 21 (2001) 1333-1339
24. George J., Afek A., Gilburd B., Levkovitz H., Shaish A., Goldberg I., et al. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138 (1998) 147-152
25. Shoenfeld Y., Wu R., Dearing L.D., and Matsuura E. Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective?. Circulation 110 (2004) 2552-2558
26. Binder C.J., Hartvgsen K., Chang M.K., Miller M., Broide D., Palinski W., et al. IL-5 links adaptive and natural immunity specific for epitopes of oxLDL and protects from atherosclerosis. J Clin Invest 114 (2004) 427-437
27. 2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques potential implication for lesion progression. Circulation 99 (1999) 2227-2230
28. Afek A., George J., Shoenfeld Y., Gilburd B., Levy Y., Shaish A., et al. Enhancement of atherosclerosis in beta-2 glycoprotein I-immunized apolipoprotein E-deficient mice. Pathobiology 67 (1999) 19-25
29. 2-glicoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 46 (2002) 2686-2694
30. Xu Q., Willeit J., Marosi M., Kleindienst R., Oberhollenzer F., Kiechl S., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341 (1993) 255-259
31. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 (2000) 14-20
32. Xu Q., Kiechl S., Mayr M., Metzler B., Egger G., Oberhollenzer F., et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100 (1999) 1169-1174
33. Mandal K., Foteinos G., Jahangiri M., and Xu Q. Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 14 (2005) 742-746
34. Afek A., George J., Gilburd B., Rauova L., Goldberg I., Kopolovic J., et al. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 14 (2000) 115-121
35. 2-glycoprotein I: implication as an atherogenic autoantigen. J Lipid Res 44 (2003) 716-726
36. 2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J Lipid Res 42 (2001) 697-709
37. 2-glycoprotein I mediates autoantibody-dependent uptake of oxidized LDL by macrophages. J Lipid Res 43 (2002) 1486-1495
38. 2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14 (2005) 736-741
39. Bassi N., Ghirardello A., Iaccarino L., Zampieri S., Rampudda M.E., Atzeni F., et al. 5th international congress on autoimmunity, Sorrento, Italy, November 29-December 3. Autoimmun Rev vol. 12 (2006) 19-20
40. Sherer Y., Gerli R., Gilburd B., Bartoloni Bocci E., Vaudo G., Mannarino E., et al. Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies. Lupus 16 (2007) 259-264